Luc Henry
CEO and co-founder at Limula | Lausanne, Vaud, Switzerland
Luc Henry’s Email & Phone Number
VerifiedFree account · No credit card · 5 profiles/month
CEO and co-founder at Limula in January 2020 - Present
Visiting Scientist at EPFL (École polytechnique fédérale de Lausanne) in January 2021 - September 2022
Visiting Scientist at University of Geneva in October 2020 - September 2022
Co-founder Science Booster at wemakeit.ch GmbH in November 2016 - December 2021
Scientific Advisor to the President at Ecole polytechnique fédérale de Lausanne in January 2017 - March 2020
co-founder and President at Hackuarium in April 2014 - December 2019
Scientific Advisor at SNSF in May 2016 - December 2016
Managing Editor at LargeNetwork in November 2014 - December 2015
Editorial Board Member at LIFT Conference in August 2014 - December 2015
Freelance Writer at The Conversation UK in June 2013 - October 2014
Postdoctoral Fellow at EPFL in November 2012 - October 2014
Visiting Researcher at Universität Ulm in January 2013 - September 2013
Postdoctoral Researcher at University of Lausanne in March 2012 - October 2012
Cross-Cultural Trainer at Cartus in January 2010 - December 2011
Research Assistant at EPFL in January 2007 - January 2007
University of Oxford, January 2008 to January 2012
Uppsala universitet, January 2004 to January 2005
EPFL (École polytechnique fédérale de Lausanne), January 2002 to January 2004
Limula provides an innovative solution for the production of the most personalised cancer treatments on demand and at scale. Our product is a unique proprietary platform can perform multiple steps of cell therapy manufacturing in a single device, using end-to-end automation and integrated process analytics.
Discover more about Limula
Please connect with my new profile: Pierre A Morgon, PharmD, LL.M, MBA
In Vitro Diagnostics, Medical Devices, Patient Management Services, Preventive Medicine and Nutrition
Cell & Gene Therapy New Business Coach
Business development for start-ups and scale-ups in regenerative medicine , cell- & gene-therapy
Very knowledgeable on market transfer
Broad industrial experience in IP-strategies and valuations
Non-dilutive Funding , Equity Investment & Venture Capital
Working through exte...
Business Development in Cell & Gene Therapy
Life science consultant - supporting operations & business development.
Supported companies:
- Limula (www.Limula.ch)
- Go by Yourself (www.gby.swiss)
- Orgenesis (www.orgenesis.com)
- Links to Water Development (www.links2water.ch)
- OrphaCare (www.OrphaCare.com)
- Educell /...
Limula: Making cell & gene therapy easy
INOTIO
/'InǝƱ∫i:ǝƱ/ noun
1. innovative technical ideas put into action
Interested in the process of IP generation and go-to-market strategies. Often the largest hurdle for innovation lies around the business model rather than the tech itself, and much research effort is...
Product Lead @ Limula | PhD in Biomedical Engineering
Limula is on a mission to make personalized cell therapies more accessible through automation and innovation. I focus on aligning our solutions with market needs, driving product development, and fostering strong customer relationships.
Thrilled to contribute to transforming ...
Cell & Gene Therapy Specialist – Limula
- Support business development and corporate strategy through pipeline management, CRM implementation and optimisation, opportunity qualification, customer engagement, and market opportunity identification.
- Develop storytelling driven marketing and scientific materials inclu...
What is Luc Henry email address?
Email Luc Henry at [email protected]. This email is the most updated Luc Henry's email found in 2026.
What is Luc Henry phone number?
Luc Henry phone number is +41766932300.
How to contact Luc Henry?
To contact Luc Henry send an email to [email protected]. If you want to call Luc Henry try calling on +41766932300.
What company does Luc Henry work for?
Luc Henry works for Limula.
What is Luc Henry's role at Limula?
Luc Henry is CEO and co-founder
What industry does Luc Henry work in?
Luc Henry works in the Higher Education industry.
